LAMOTRIGINE Safety Questions, LAMOTRIGINE Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about LAMOTRIGINE. Our extensive database of LAMOTRIGINE adverse events and LAMOTRIGINE warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about LAMOTRIGINE

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




LAMOTRIGINE Safety Reports

Total LAMOTRIGINE reports: 273.
LAMOTRIGINE FDA safety alerts: 2001 2006 .
Reported deaths: 29    Reported hospitalizations: 91.
Take LAMOTRIGINE Side Effects Survey or Share Your LAMOTRIGINE Story. LAMOTRIGINE Usage.

Showing 1-75 of 273 Next >

Physician from CANADA reported LAMOTRIGINE problem on Apr 02, 2007. Female patient, 38 years of age, was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: unintended pregnancy. LAMOTRIGINE dosage: 300MG PER DAY. During the same period patient was treated with MORNING AFTER, BENZODIAZEPINE. Patient recovered.

LAMOTRIGINE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 04, 2007. Male patient, child 8 years of age, was diagnosed with partial seizures and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: convulsion, migraine. LAMOTRIGINE dosage: 150MG TWICE PER DAY. During the same period patient was treated with CLARITIN, TYLENOL, MOTRIN. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported LAMOTRIGINE problem on Apr 02, 2007. Female patient, 18 years of age, was diagnosed with epilepsy, obesity and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: convulsion. LAMOTRIGINE dosage: 200MG PER DAY. During the same period patient was treated with ORLISTAT. Patient was hospitalized. Patient recovered.

LAMOTRIGINE problem was reported by a Health Professional from UNITED STATES on Apr 06, 2007. Female patient, 37 years of age, was diagnosed with bipolar disorder and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: abortion induced, abortion spontaneous. LAMOTRIGINE dosage: 200MG PER DAY. During the same period patient was treated with PAROXETINE, QUETIAPINE FUMARATE. Patient recovered.

Physician from BELGIUM reported LAMOTRIGINE problem on Apr 04, 2007. Female patient, 36 years of age, was diagnosed with bipolar disorder and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: coordination abnormal, joint stiffness, somnolence, suicide attempt, vomiting. LAMOTRIGINE dosage: unknown. During the same period patient was treated with MIRTAZAPINE, PROZAC, XANAX. Patient recovered.

LAMOTRIGINE problem was reported by a Consumer or non-health professional from NETHERLANDS on Apr 10, 2007. Male patient, child 2 years of age, weighting 35.27 lb, was diagnosed with epilepsy and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, anxiety, aphasia, confusional state, dissociation, dyskinesia, epilepsy, hallucination, memory impairment. LAMOTRIGINE dosage: 5MG SEE TEXT. During the same period patient was treated with DEPAKENE. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported LAMOTRIGINE problem on Apr 16, 2007. Female patient, weighting 8.60 lb, was diagnosed with bipolar disorder and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: hypospadias, talipes. LAMOTRIGINE dosage: unknown. Patient recovered.

LAMOTRIGINE problem was reported by a Pharmacist from UNITED STATES on Apr 19, 2007. Male patient, child 10 years of age, weighting 79.37 lb, was diagnosed with convulsion and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: respiratory distress, somnolence, stevens-johnson syndrome, vomiting, wheezing. LAMOTRIGINE dosage: 25 MG BID PO (DOSE TITRATION FOR 3 WEEK). Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported LAMOTRIGINE problem on Apr 17, 2007. Female patient was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: accidental overdose, activities of daily living impaired, cerebellar syndrome, confusional state, coordination abnormal, haematemesis, headache. LAMOTRIGINE dosage: unknown. During the same period patient was treated with VALPROATE, ADRENALINE. Patient was hospitalized and became disabled. Patient recovered.

LAMOTRIGINE problem was reported by a Physician from KOREA, REPUBLIC OF on Apr 16, 2007. Male patient, 34 years of age, was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: diarrhoea, epidermolysis, influenza, leukocytosis, pneumonia, pyrexia, rash, stevens-johnson syndrome. LAMOTRIGINE dosage: unknown. During the same period patient was treated with ZONISAMIDE. Patient was hospitalized. Patient recovered.

Physician from BELGIUM reported LAMOTRIGINE problem on Apr 20, 2007. Male patient, weighting 198.4 lb, was diagnosed with bipolar disorder and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: dermatitis, psoriasis, skin lesion, thermal burn. LAMOTRIGINE dosage: 200MG PER DAY. During the same period patient was treated with MANIPREX, CLOZAPINE, SIPRALEXA, SANDIMMUNE, TRANXENE. Patient was hospitalized and became disabled. Patient recovered.

LAMOTRIGINE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 11, 2007. Male patient was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: accidental overdose, blood pressure decreased, crying, grand mal convulsion, irritability, mydriasis, respiratory rate increased, sinus tachycardia. LAMOTRIGINE dosage: 25 MG/ORAL. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported LAMOTRIGINE problem on Apr 24, 2007. Male patient, 45 years of age, weighting 191.8 lb, was diagnosed with back pain and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: alcohol use, back pain, feeling hot and cold, hyperhidrosis, inadequate analgesia, incorrect dose administered, nausea, overdose, tremor. LAMOTRIGINE dosage: 200 MG BID PO. Patient was hospitalized. Patient recovered.

LAMOTRIGINE problem was reported by a Health Professional from UNITED STATES on Apr 18, 2007. Male patient was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: accidental overdose, blood pressure decreased, convulsion, crying, emotional distress, irritability, sinus tachycardia, vomiting. LAMOTRIGINE dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported LAMOTRIGINE problem on Dec 12, 2006. Male patient, child 10 years of age, weighting 61.07 lb, was diagnosed with epilepsy and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: convulsion, rash. LAMOTRIGINE dosage: (25 MG), ORAL. During the same period patient was treated with VALPROIC ACID, LORAZEPAM. Patient recovered.

LAMOTRIGINE problem was reported by a Physician from RUSSIAN FEDERATION on Apr 25, 2007. Female patient, 36 years of age, weighting 180.8 lb, was diagnosed with partial seizures, epilepsy and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: cardiac failure acute, fall. LAMOTRIGINE dosage: unknown. During the same period patient was treated with PHENYTOIN. Patient died on 02/20/2007.

Health Professional from UNITED STATES reported LAMOTRIGINE problem on May 02, 2007. Female patient was diagnosed with bipolar disorder and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: premature baby. LAMOTRIGINE dosage: 300MG PER DAY. During the same period patient was treated with ESCITALOPRAM OXALATE. Patient recovered.

LAMOTRIGINE problem was reported by a Health Professional from UNITED STATES on May 02, 2007. Female patient was diagnosed with bipolar disorder and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: caesarean section, premature baby, pulmonary valve stenosis, pulmonary valve stenosis congenital. LAMOTRIGINE dosage: 300MG PER DAY. During the same period patient was treated with ESCITALOPRAM OXALATE. Patient recovered.

Consumer or non-health professional from GERMANY reported LAMOTRIGINE problem on May 02, 2007. Female patient, 62 years of age, was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: choking, dyspnoea, tongue disorder. LAMOTRIGINE dosage: 325MG PER DAY. Patient was hospitalized. Patient recovered.

LAMOTRIGINE problem was reported by a Health Professional from UNITED STATES on May 07, 2007. Female patient was diagnosed with epilepsy and was treated with LAMOTRIGINE. LAMOTRIGINE dosage: 700MG PER DAY. Patient died on 06/24/2006.

Consumer or non-health professional from SWITZERLAND reported LAMOTRIGINE problem on May 04, 2007. Male patient was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: heart disease congenital. LAMOTRIGINE dosage: 100MG TWICE PER DAY. Patient recovered.

LAMOTRIGINE problem was reported by a Physician from UNITED STATES on May 07, 2007. Male patient, child 8 years of age, weighting 68.34 lb, was diagnosed with epilepsy and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, discomfort. LAMOTRIGINE dosage: 50 MG BID PO. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported LAMOTRIGINE problem on May 04, 2007. Female patient, 18 years of age, was diagnosed with obesity and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: convulsion, malabsorption. LAMOTRIGINE dosage: 200MG PER DAY. During the same period patient was treated with XENICAL. Patient recovered.

LAMOTRIGINE problem was reported by a Health Professional from UNITED STATES on May 09, 2007. Female patient, 32 years of age, was diagnosed with bipolar disorder and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: abortion induced. LAMOTRIGINE dosage: 200MG PER DAY. During the same period patient was treated with KLONOPIN, ADDERALL, TRAZODONE. Patient recovered.

Health Professional from UNITED STATES reported LAMOTRIGINE problem on May 09, 2007. Male patient, weighting 189.0 lb, was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: pneumonia, treatment noncompliance. LAMOTRIGINE dosage: 200MG BID PO. Patient recovered.

LAMOTRIGINE problem was reported by a Health Professional from UNITED STATES on May 11, 2007. Female patient, 30 years of age, was diagnosed with bipolar disorder and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. LAMOTRIGINE dosage: unknown. During the same period patient was treated with ZYPREXA, AMBIEN. Patient recovered.

Physician from UNITED STATES reported LAMOTRIGINE problem on May 14, 2007. Male patient, 27 years of age, was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, appendicitis perforated, incision site pain. LAMOTRIGINE dosage: 100MG PER DAY. During the same period patient was treated with OLANZAPINE. Patient was hospitalized. Patient recovered.

LAMOTRIGINE problem was reported by a Health Professional from UNITED STATES on May 14, 2007. Female patient, weighting 7.94 lb, was diagnosed with depression and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: feeding disorder neonatal, ventricular hypoplasia. LAMOTRIGINE dosage: unknown. During the same period patient was treated with PROZAC. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported LAMOTRIGINE problem on May 15, 2007. Female patient, 33 years of age, was diagnosed with epilepsy and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. LAMOTRIGINE dosage: 300MG PER DAY. Patient recovered.

LAMOTRIGINE problem was reported by a Health Professional from UNITED STATES on May 15, 2007. Male patient, weighting 6.39 lb, was diagnosed with epilepsy and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: polydactyly. LAMOTRIGINE dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported LAMOTRIGINE problem on May 16, 2007. Male patient, weighting 8.82 lb, was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: cryptorchism. LAMOTRIGINE dosage: 300MG PER DAY. During the same period patient was treated with VITAMIN AND MINERAL PRENATAL SUPPLEMENT W, FOLIC ACID. Patient recovered.

LAMOTRIGINE problem was reported by a Health Professional from UNITED STATES on May 18, 2007. Female patient was diagnosed with bipolar disorder and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: limb malformation. LAMOTRIGINE dosage: 200MG PER DAY. During the same period patient was treated with LEXAPRO. Patient recovered.

Health Professional from UNITED STATES reported LAMOTRIGINE problem on May 18, 2007. Female patient was diagnosed with bipolar disorder and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: congenital choroid plexus cyst, ventricular septal defect. LAMOTRIGINE dosage: 200MG PER DAY. During the same period patient was treated with ZOLOFT, TOPAMAX. Patient recovered.

LAMOTRIGINE problem was reported by a Consumer or non-health professional from UNITED STATES on May 22, 2007. Female patient, 17 years of age, was diagnosed with bipolar disorder and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. LAMOTRIGINE dosage: 75MG TWICE PER DAY. During the same period patient was treated with SEROQUEL. Patient recovered.

Health Professional from UNITED STATES reported LAMOTRIGINE problem on May 24, 2007. Male patient was diagnosed with bipolar disorder and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: congenital musculoskeletal anomaly, spine malformation, talipes. LAMOTRIGINE dosage: 150MG PER DAY. During the same period patient was treated with SEROQUEL. Patient was hospitalized. Patient recovered.

LAMOTRIGINE problem was reported by a Health Professional from UNITED STATES on May 25, 2007. Female patient, weighting 7.28 lb, was diagnosed with epilepsy and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: polydactyly. LAMOTRIGINE dosage: 200MG PER DAY. During the same period patient was treated with TOPAMAX. Patient recovered.

Health Professional from UNITED STATES reported LAMOTRIGINE problem on June 01, 2007. Female patient, weighting 6.83 lb, was diagnosed with bipolar disorder and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: congenital aqueductal stenosis, congenital hydrocephalus. LAMOTRIGINE dosage: unknown. During the same period patient was treated with HALDOL. Patient recovered.

LAMOTRIGINE problem was reported by a Consumer or non-health professional from UNITED STATES on May 21, 2007. Male patient, 36 years of age, was diagnosed with convulsion prophylaxis and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: aphthous stomatitis, cerebral ischaemia, depression, injury asphyxiation, metabolic disorder, suicide attempt. LAMOTRIGINE dosage: unknown. During the same period patient was treated with OXCARBAZEPINE, PHENYTOIN, VENLAFAXIINE, MIRTAZAPINE, METOPROLOL SUCCINATE, PROPRANOLOL HYDROCHLORIDE, FAMOTIDINE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LAMOTRIGINE problem on May 21, 2007. Female patient, 35 years of age, was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: aphthous stomatitis, glossodynia, oral intake reduced, pharyngolaryngeal pain, tongue ulceration. LAMOTRIGINE dosage: unknown. During the same period patient was treated with OXCARBAZEPINE, TOPIRAMATE, ARIPIPRAZOLE, CITALOPRAM HYDROBROMIDE, NAPROXEN, PANTOPRAZOLE, LEVOTHYROXINE, HYDROXYZINE HYDROCHLORIDE. Patient recovered.

LAMOTRIGINE problem was reported by a Consumer or non-health professional from TURKEY on May 30, 2007. Female patient, 23 years of age, was diagnosed with epilepsy and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: respiratory tract infection, stevens-johnson syndrome. LAMOTRIGINE dosage: 50MG, TWICE PER DAY;. During the same period patient was treated with VALPROIC ACID. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported LAMOTRIGINE problem on June 13, 2007. Male patient was diagnosed with suicidal ideation and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: cardiac murmur, heart disease congenital, talipes. LAMOTRIGINE dosage: 50MG PER DAY. During the same period patient was treated with LEXAPRO, FOLIC ACID, DEPAKOTE, GEODON. Patient recovered.

LAMOTRIGINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 08, 2007. Female patient, 35 years of age, weighting 222.7 lb, was diagnosed with pain, swelling, depression, obesity, headache and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: eyelid oedema, haemangioma, haemorrhage, hypersensitivity, pain, rash papular, swelling, wound secretion. LAMOTRIGINE dosage: 25MG TWICE PER DAY. During the same period patient was treated with BUMETANIDE, CETIRIZINE, DURAGESIC, FLUOXETINE, LANSOPRAZOLE, ORLISTAT. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported LAMOTRIGINE problem on June 11, 2007. Female patient, 27 years of age, weighting 144.8 lb, was diagnosed with epilepsy, contraception and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: pregnancy. LAMOTRIGINE dosage: 100MG PER DAY. During the same period patient was treated with CERAZETTE. Patient recovered.

LAMOTRIGINE problem was reported by a Consumer or non-health professional from TURKEY on May 31, 2007. Female patient, 23 years of age, was diagnosed with epilepsy and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: respiratory tract infection, stevens-johnson syndrome, urinary tract infection. LAMOTRIGINE dosage: unknown. During the same period patient was treated with VALPROIC ACID, CARBAMAZEPINE, PHENOXYMETHYLPENICILLIN, ORNIDAZOLE, VALPROIC ACID. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported LAMOTRIGINE problem on June 06, 2007. Female patient, 50 years of age, was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, blood creatine phosphokinase increased, depressed level of consciousness, electrocardiogram qt prolonged, myoclonus, pneumonia, serotonin syndrome. LAMOTRIGINE dosage: unknown. During the same period patient was treated with OLANZAPINE. Patient was hospitalized. Patient recovered.

LAMOTRIGINE problem was reported by a Consumer or non-health professional from UNITED STATES on June 26, 2007. Female patient, 32 years of age, was diagnosed with bipolar disorder and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: normal delivery, pregnancy on oral contraceptive. LAMOTRIGINE dosage: unknown. During the same period patient was treated with ORTHO, PROZAC, SEROQUEL. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported LAMOTRIGINE problem on June 11, 2007. Female patient, 27 years of age, was diagnosed with epilepsy, contraception and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: pregnancy on oral contraceptive. LAMOTRIGINE dosage: 100 MG (100 MG, 1 IN 1 D) ORAL. During the same period patient was treated with DESOGESTREL. Patient recovered.

LAMOTRIGINE problem was reported by a Physician from BELGIUM on June 19, 2007. Female patient, 36 years of age, weighting 132.3 lb, was diagnosed with bipolar disorder and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: coordination abnormal, fatigue, joint stiffness, musculoskeletal stiffness, overdose, somnolence, suicide attempt. LAMOTRIGINE dosage: unknown. During the same period patient was treated with MIRTAZAPINE, PROZAC, XANAX, BENZODIAZEPINES. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported LAMOTRIGINE problem on June 19, 2007. Female patient, 50 years of age, was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: depressed level of consciousness, electrocardiogram qt prolonged, pneumonia, serotonin syndrome. LAMOTRIGINE dosage: unknown. During the same period patient was treated with ZOPICLONE, ESCITALOPRAM OXALATE, OLANZAPINE. Patient was hospitalized. Patient recovered.

LAMOTRIGINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 18, 2007. Female patient was diagnosed with epilepsy and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: abdominal wall anomaly, abortion induced, cardiac disorder, foetal disorder, renal aplasia, spina bifida. LAMOTRIGINE dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported LAMOTRIGINE problem on Mar 25, 2006. Female patient, 57 years of age, was diagnosed with convulsion and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: cyanosis, dyspnoea, interstitial lung disease, tachycardia. LAMOTRIGINE dosage: 75MG PER DAY. During the same period patient was treated with VALPROIC ACID. Patient recovered.

LAMOTRIGINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 27, 2006. Female patient, 57 years of age, was diagnosed with convulsion and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: cyanosis, dyspnoea, interstitial lung disease, tachycardia. LAMOTRIGINE dosage: 75MG PER DAY. During the same period patient was treated with VALPROIC ACID. Patient recovered.

Physician from NETHERLANDS reported LAMOTRIGINE problem on June 29, 2006. Female patient was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: balance disorder, coordination abnormal, gait disturbance. LAMOTRIGINE dosage: 150MG TWICE PER DAY. Patient recovered.

LAMOTRIGINE problem was reported by a Health Professional from UNITED STATES on May 18, 2006. Female patient, 23 years of age, was diagnosed with epilepsy and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: placental disorder, premature labour, thrombosis. LAMOTRIGINE dosage: 300MG PER DAY. During the same period patient was treated with TOPAMAX. Patient died.

Physician from INDIA reported LAMOTRIGINE problem on June 26, 2006. Female patient, 39 years of age, was diagnosed with partial seizures and was treated with LAMOTRIGINE. LAMOTRIGINE dosage: 50MG PER DAY. Patient died on 06/25/2006.

LAMOTRIGINE problem was reported by a Physician from BELGIUM on June 14, 2006. Male patient, 30 years of age, was diagnosed with bipolar disorder and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: completed suicide. LAMOTRIGINE dosage: 200MG PER DAY. During the same period patient was treated with LITHIUM CARBONATE. Patient died on 06/12/2006.

Pharmacist from UNITED STATES reported LAMOTRIGINE problem on July 11, 2006. Male patient, weighting 264.6 lb, was diagnosed with bipolar i disorder and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: gamma-glutamyltransferase increased. LAMOTRIGINE dosage: 100MG QHS PO. During the same period patient was treated with APAP, ASPIRIN, FOLIC ACID, LANTUS, METFORMIN, PROTONIX, AVANDIA, TRAZODONE. Patient recovered.

LAMOTRIGINE problem was reported by a Health Professional from NETHERLANDS on June 21, 2006. Female patient, 48 years of age, was diagnosed with epilepsy and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: pericardial effusion. LAMOTRIGINE dosage: 175 MILLIGRAM ORAL. During the same period patient was treated with VALPROATE. Patient recovered.

Physician from GERMANY reported LAMOTRIGINE problem on June 08, 2006. Female patient, 42 years of age, weighting 163.1 lb, was diagnosed with schizophrenia, schizophrenia, paranoid type and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: electroencephalogram abnormal, neutrophil count decreased, salivary hypersecretion, white blood cell count decreased. LAMOTRIGINE dosage: unknown. During the same period patient was treated with SOLIAN, TRUXAL, DIPIPERON, DIAZEPAM, BELLADONNYSAT, LEPONEX. Patient was hospitalized. Patient recovered.

LAMOTRIGINE problem was reported by a Physician from BELGIUM on July 10, 2006. Female patient, 68 years of age, was diagnosed with bipolar disorder and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: atrioventricular block first degree, bradycardia, renal failure, syncope. LAMOTRIGINE dosage: unknown. During the same period patient was treated with LORMETAZEPAM, BISOPROLOL FUMARATE, MIRTAZAPINE, FLUOXETINE, CANDESARTAN, HYDROCHLOROTHIAZIDE, ATORVASTATIN CALCIUM. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported LAMOTRIGINE problem on July 13, 2006. Female patient, 16 years of age, weighting 110.2 lb, was diagnosed with convulsion and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: gait disturbance, hypotension, nausea, pharyngeal erythema, pyrexia, rash morbilliform. LAMOTRIGINE dosage: 25 MG QOD. During the same period patient was treated with VALPROIC ACID. Patient was hospitalized. Patient recovered.

LAMOTRIGINE problem was reported by a Pharmacist from UNITED STATES on July 12, 2006. Female patient, weighting 152.0 lb, was diagnosed with mood altered, upper respiratory tract infection and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: hepatitis, upper respiratory tract infection. LAMOTRIGINE dosage: 100 MG BID PO. During the same period patient was treated with LEVOFLOXACIN, LEVOTHYROXINE, DIPHENHYDRAMINE, PSYLLIUM, DOCUSATE, RISPERIDONE, CLONAZEPAM, BENZTROPINE MESYLATE. Patient was hospitalized. Patient recovered.

Physician from INDIA reported LAMOTRIGINE problem on June 26, 2006. Female patient, 39 years of age, was diagnosed with partial seizures, gastritis and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, grand mal convulsion, pneumonia aspiration, pyrexia, vomiting. LAMOTRIGINE dosage: 50MG PER DAY. During the same period patient was treated with DIAZEPAM, RANTAC, FLUIDS, CARBAMAZEPINE. Patient was hospitalized. Patient died on 06/25/2006.

LAMOTRIGINE problem was reported by a Pharmacist from UNITED STATES on July 19, 2006. Male patient was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: rash. LAMOTRIGINE dosage: 50 MG DAILY PO. During the same period patient was treated with RIMANTIDINE, QUETIAPINE FUMARATE, LISINOPRIL, HYDROCHLOROTHIAZIDE, DIVALPROEX, ASPIRIN, ACETAMINOPHEN AND HYDROCODONE BITARTRATE. Patient recovered.

Physician from UNITED STATES reported LAMOTRIGINE problem on July 20, 2006. Female patient, weighting 175.0 lb, was diagnosed with bipolar i disorder and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: arthralgia, chills, lethargy, oedema peripheral, somnolence. LAMOTRIGINE dosage: 300 MG PO. During the same period patient was treated with EFFEXOR, XANAX. Patient recovered.

LAMOTRIGINE problem was reported by a Physician from BELGIUM on June 28, 2006. Male patient, 45 years of age, was diagnosed with bipolar disorder, depression and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: aphthous stomatitis, erythrodermic psoriasis, mucous membrane disorder, pain, skin chapped, skin exfoliation, swelling face, tongue ulceration. LAMOTRIGINE dosage: unknown. During the same period patient was treated with DEPAKENE, EFFEXOR. Patient recovered.

Pharmacist from UNITED STATES reported LAMOTRIGINE problem on July 24, 2006. Female patient, 68 years of age, was diagnosed with hypomania and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: emotional distress, oral soft tissue disorder, rash, rash macular, rash pustular. LAMOTRIGINE dosage: unknown. Patient recovered.

LAMOTRIGINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 25, 2006. Female patient, weighting 251.3 lb, was diagnosed with trigeminal neuralgia and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: blood folate decreased, macrocytosis. LAMOTRIGINE dosage: unknown. During the same period patient was treated with BECLOMETHASONE DIPROPIONATE, CODEIN PHOSPHATE, LANSOPRAZOLE, ALBUTEROL SPIROS. Patient recovered.

Physician from INDIA reported LAMOTRIGINE problem on June 26, 2006. Female patient, 39 years of age, was diagnosed with partial seizures, gastritis and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, grand mal convulsion, pneumonia aspiration, pyrexia, vomiting. LAMOTRIGINE dosage: 50MG PER DAY. During the same period patient was treated with DIAZEPAM, RANTAC, FLUIDS, CARBAMAZEPINE. Patient was hospitalized. Patient died on 06/25/2006.

LAMOTRIGINE problem was reported by a Health Professional from UNITED STATES on July 31, 2006. Female patient was diagnosed with epilepsy and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. LAMOTRIGINE dosage: 100MG TWICE PER DAY. During the same period patient was treated with FOLIC ACID. Patient was hospitalized. Patient recovered.

Physician from INDIA reported LAMOTRIGINE problem on June 26, 2006. Female patient, 39 years of age, was diagnosed with partial seizures, convulsion, gastritis and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, grand mal convulsion, pneumonia aspiration, pyrexia, vomiting. LAMOTRIGINE dosage: 50MG PER DAY. During the same period patient was treated with DIAZEPAM, RANTAC, FLUIDS, CARBAMAZEPINE. Patient was hospitalized. Patient died on 06/25/2006.

LAMOTRIGINE problem was reported by a Health Professional from UNITED STATES on Aug 03, 2006. Female patient, 26 years of age, was diagnosed with bipolar disorder and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. LAMOTRIGINE dosage: 300MG PER DAY. Patient recovered.

Health Professional from UNITED STATES reported LAMOTRIGINE problem on Aug 03, 2006. Female patient was diagnosed with bipolar disorder and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: neonatal disorder, pyloric stenosis, vomiting, vomiting neonatal. LAMOTRIGINE dosage: 100MG PER DAY. During the same period patient was treated with SEROQUEL, PRENATAL VITAMINS. Patient was hospitalized. Patient recovered.

LAMOTRIGINE problem was reported by a Health Professional from UNITED STATES on Aug 02, 2006. Female patient, 42 years of age, was diagnosed with bipolar disorder and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: gestational diabetes, normal newborn, pre-eclampsia, premature labour, premature separation of placenta. LAMOTRIGINE dosage: 100MG PER DAY. During the same period patient was treated with BUPROPION, PAXIL, KLONOPIN. Patient recovered.

Health Professional from UNITED STATES reported LAMOTRIGINE problem on Aug 02, 2006. Female patient, weighting 5.07 lb, was diagnosed with bipolar disorder and was treated with LAMOTRIGINE. After drug was administered, patient experienced the following problems/side effects: normal newborn, premature baby, small for dates baby. LAMOTRIGINE dosage: 100MG PER DAY. During the same period patient was treated with BUPROPION, PAXIL, KLONOPIN. Patient recovered.

Showing 1-75 of 273 Next >

Ask Our Patient Community about LAMOTRIGINE

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)